![Jean-Charles Soria: Delving into the future of cancer treatment with new ADC formats](https://oncodaily.com/pub/uploads/2023/09/1536342055336-1280x1280.jpg)
Photo taken from Jean-Charles Soria/LinkedIn
Jan 24, 2024, 22:11
Jean-Charles Soria: Delving into the future of cancer treatment with new ADC formats
Jean-Charles Soria, Senior Vice President of Oncology within Global Development at Amgen, posted the following on LinkedIn:
“Delving into the future of cancer treatment with new ADC formats: Bispecific ADCs targeting multiple antigens, Dual-drug ADCs combining different cytotoxins, Probody-drug conjugates for enhanced tumor specificity, Immune-stimulating ADCs, Protein-degrader ADCs & other formats pushing the frontiers of oncology.”
Read further.
Source: Jean-Charles Soria/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023